BioStem Technologies to present at H.C. Wainwright global investment conference
BioStem Technologies Inc. (BSEM) said it will present at the H.C. Wainwright 28th Annual Global Investment Conference.
POMPANO BEACH, Fla., Sept.
03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc.
NASDAQ:BSEM (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company m…